Narus Financial Partners LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, Holdings Channel reports. The firm bought 4,452 shares of the company’s stock, valued at approximately $222,000.
Other institutional investors have also recently modified their holdings of the company. Neuburgh Advisers LLC raised its position in shares of HealthEquity by 0.4% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company’s stock worth $1,357,000 after buying an additional 112 shares during the period. Glen Harbor Capital Management LLC raised its position in shares of HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock worth $1,866,000 after buying an additional 154 shares during the period. Elkfork Partners LLC raised its position in shares of HealthEquity by 0.4% in the first quarter. Elkfork Partners LLC now owns 55,944 shares of the company’s stock worth $2,375,000 after buying an additional 196 shares during the period. State of Alaska Department of Revenue raised its position in shares of HealthEquity by 4.3% in the first quarter. State of Alaska Department of Revenue now owns 4,850 shares of the company’s stock worth $205,000 after buying an additional 200 shares during the period. Finally, Allegis Investment Advisors LLC raised its position in shares of HealthEquity by 2.4% in the first quarter. Allegis Investment Advisors LLC now owns 10,237 shares of the company’s stock worth $435,000 after buying an additional 237 shares during the period. Institutional investors own 91.92% of the company’s stock.
HealthEquity, Inc. (NASDAQ HQY) traded down 3.15% during trading on Monday, hitting $48.61. The company’s stock had a trading volume of 285,464 shares. HealthEquity, Inc. has a one year low of $27.45 and a one year high of $54.95. The company has a 50-day moving average of $48.61 and a 200 day moving average of $45.03. The firm has a market cap of $2.92 billion, a PE ratio of 91.37 and a beta of 1.79.
HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The business had revenue of $55.40 million during the quarter, compared to analysts’ expectations of $54.77 million. During the same period in the prior year, the company earned $0.15 earnings per share. The business’s revenue was up 25.9% compared to the same quarter last year. On average, equities analysts forecast that HealthEquity, Inc. will post $0.58 earnings per share for the current year.
A number of brokerages recently issued reports on HQY. Cantor Fitzgerald raised their target price on HealthEquity from $50.00 to $55.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 7th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $61.00 target price (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Chardan Capital lifted their price objective on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th. Wells Fargo & Company initiated coverage on HealthEquity in a research note on Tuesday, March 14th. They set an “outperform” rating for the company. Finally, J P Morgan Chase & Co lifted their price objective on HealthEquity from $44.00 to $51.00 and gave the company an “overweight” rating in a research note on Wednesday, March 22nd. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. HealthEquity presently has a consensus rating of “Buy” and a consensus target price of $48.56.
In other HealthEquity news, major shareholder Berkley Capital, Llc sold 210,398 shares of the stock in a transaction dated Friday, July 7th. The shares were sold at an average price of $50.26, for a total value of $10,574,603.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 1,095 shares of the stock in a transaction dated Thursday, April 13th. The shares were sold at an average price of $43.60, for a total transaction of $47,742.00. Following the completion of the transaction, the executive vice president now directly owns 5,132 shares of the company’s stock, valued at $223,755.20. The disclosure for this sale can be found here. Insiders have sold 1,407,712 shares of company stock valued at $72,065,845 over the last three months. 29.00% of the stock is currently owned by corporate insiders.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2286087/narus-financial-partners-llc-takes-position-in-healthequity-inc-hqy.html
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.